Navigation Links
Perrigo Announces FDA Final Approval for Miconazole
Date:6/3/2010

ALLEGAN, Mich., June 3 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Miconazole Nitrate Vaginal Cream and Suppository, a generic to Monistat® -1 Combination Pack. Perrigo expects to begin shipping immediately.  

Monistat® -1 has annual retail sales of approximately $90 million dollars.  This OTC product is indicated for the treatment of vaginal yeast infections and for the relief of external itching and irritation they cause. Perrigo was the first to file an ANDA containing a Paragraph IV certification, and the resulting patent litigation filed by Johnson & Johnson was previously dismissed. Perrigo's approval includes 180 days of generic marketing exclusivity.  

Perrigo's Chairman and CEO Joseph C. Papa concluded, "This is another example of Perrigo's commitment to innovation by challenging brand patents and bringing new products to market. These innovations help save OTC healthcare consumers more than an estimated $1 billion annually."      

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing and logistics operations are

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Perrigo Acquires Rights to Generic Version of HalfLytely® from Novel Laboratories
2. Perrigo Company to Present at the Citi Investment Research Global Health Care Conference
3. Perrigo Company Announces Quarterly Dividend
4. Perrigo Acquires Infant Formula Manufacturer PBM Holdings for $808 Million
5. Perrigo Company Announces Quarterly Dividend
6. Perrigo Company Will Release Second Quarter Fiscal 2010 Results on February 2, 2010
7. Perrigo Company to Present at the 28th Annual J.P. Morgan Healthcare Conference
8. Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix
9. Perrigo Company To Present at the Sidoti Emerging Growth Conference
10. Perrigo Company Announces Dividend Increase
11. Perrigo Company Will Release First Quarter Fiscal 2010 Results on November 2, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), ... repair and regeneration, today announced that J.J. Finkelstein ... present a corporate overview at two upcoming investor conferences. ... SeeThruEquity 4 th Annual Microcap Conference on Thursday ... at 11:00 am EDT.  A webcast will ...
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma ... diagnosed victims of mesothelioma get the best possible ... certain individuals with this rare cancer caused by ... most up-to-date information related to treatment options such ... please call the Mesothelioma Victims Center anytime at ...
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
(Date:5/22/2015)... 22, 2015 The American College of ... in June. They will hold a webinar on the ... two-day class on Classical Chinese Medicine. , Webinar – ... Steve Given, the Dean of Clinical Education, will lead ... First Professional Doctorate program. ACTCM is currently developing this ...
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health ... health brand Nature’s Way, Marc St-Onge has affirmed his ... Skin is an integral part of the agreement with ... to further develop Ascenta Skin into a leading player ... a breakthrough, anti-aging skincare supplement featuring 6 active ingredients ...
(Date:5/22/2015)... Topsfield, MA (PRWEB) May 22, 2015 ... Keri Hart, MS/CCC, SLP, RAC-CT, CHHRP-QT, Vice President ... International, “A very important ‘language’ that impacts how ... International, the leader in long term care reimbursement, ... and education programs and talent management, launches a ...
(Date:5/22/2015)... R.I. (PRWEB) May 22, 2015 Memorial Day ... Amica Insurance is offering some tips to help ... Safety Council, there will be 383 traffic fatalities this Memorial ... from the National Highway Traffic Safety Association: , ... in the vehicle is wearing a seatbelt, whether they’re driving ...
(Date:5/22/2015)... ZH Healthcare (ZH), ... today that Bill Lane, joins ZH’s Advisory Board. ... BlueEHS,a first of its kind, Freemium SaaS, Electronic ... Health Records (EHR) with an integrated practice management ... patient portal, and more. Combined with its Revenue ...
Breaking Medicine News(10 mins):Health News:ACTCM Announces Upcoming June Events 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:ZH Healthcare Adds Bill Lane to Advisory Board 2
... FRIDAY, July 8 (HealthDay News) -- Young women say they flock ... their natural beauty, protects them from the sun,s rays and fills ... lasting. A deep tan may help project beauty and confidence ... give way to permanent skin damage caused by the ultraviolet rays ...
... main treatment for HER2-positive metastatic breast cancer, helps some ... Herceptin-based therapies, according to a study led by researchers ... and published in the Journal of Clinical Oncology. ... the targeted therapies, which play different roles in cancer, ...
... , FRIDAY, July 8 (HealthDay News) ... and biofeedback to help prevent chronic migraine headaches ... study suggests. Researchers compared the costs of ... drugs. After six months, minimal-contact behavioral treatment was ...
... , FRIDAY, July 8 (HealthDay News) -- Along with rising ... an open window also increases, experts say, with many children ... years and younger are treated for falls from windows, according ... 5 years, the majority of a child,s weight is concentrated ...
... For the past decade, researchers have tried to reprogram the ... one of the most sought-after cells in regenerative medicine because ... by replacing lost tissue. Now, researchers at the Perelman School ... to demonstrate the direct conversion of a non-heart cell type ...
... , FRIDAY, July 8 (HealthDay News) -- Obese people ... likely to suffer from complications than those of normal ... outcomes are often used by insurance companies, the Johns ... doctors and hospitals are reimbursed for more complex procedures ...
Cached Medicine News:Health News:A Safe Tan? No Way, Experts Say 2Health News:A Safe Tan? No Way, Experts Say 3Health News:A Safe Tan? No Way, Experts Say 4Health News:Targeted agent addition to herceptin has positive effect on metastatic HER-2 breast cancer 2Health News:Targeted agent addition to herceptin has positive effect on metastatic HER-2 breast cancer 3Health News:Windows Pose Safety Risk for Young Children, Experts Warn 2Health News:A change of heart: Penn researchers reprogram brain cells to become heart cells 2Health News:Obesity May Increase Risk of Surgical Complications 2
... its great versatility in epilation and ... the compactness and easy-transportability of the ... protocols developed for Smartepil II plus, ... indicated for hair removal of tricky ...
... Plus is a CO2 laser system ... W. Its functions in continuous and ... requiring extreme laser intervention delicacy. Excellent ... studios, it comes with a large ...
... Performance ZyDoc offers HIPAA-secure web-based access to ... days a week through the utilization of ... documents, listen to the original dictation at ... electronically sign the document, and fax to ...
Auto Refkeratomoeter...
Medicine Products: